Equities

Pharmena SA

PHR:WSE

Pharmena SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (PLN)4.97
  • Today's Change0.12 / 2.47%
  • Shares traded812.00
  • 1 Year change-14.31%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

As of last trade Pharmena SA (PHR:WSE) traded at 4.97, 6.88% above its 52-week low of 4.65, set on Nov 12, 2024.
52-week range
Today
4.65Nov 12 20249.18Apr 03 2024
Open4.88
High4.97
Low4.72
Bid4.80
Offer4.97
Previous close4.85
Average volume1.93k
Shares outstanding11.14m
Free float3.31m
P/E (TTM)1.91
Market cap55.35m PLN
EPS (TTM)2.60
PLN
Annual div (ADY)--
Annual div yield (ADY)--
Div ex-dateAug 03 2016
Div pay-dateAug 18 2016
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.